|
INTS8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.22389933929912E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.93570000531318E-08 |
| Normal-vs-Stage2 |
9.18359999158014E-09 |
| Normal-vs-Stage3 |
8.940292950399E-12 |
| Normal-vs-Stage4 |
4.81814588226825E-12 |
| Stage1-vs-Stage2 |
1.099550E-01 |
| Stage1-vs-Stage3 |
5.557000E-03 |
| Stage1-vs-Stage4 |
7.359200E-04 |
| Stage2-vs-Stage3 |
6.511400E-01 |
| Stage2-vs-Stage4 |
2.740000E-01 |
| Stage3-vs-Stage4 |
4.775600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.39970298976777E-11 |
| Normal-vs-AfricanAmerican |
2.26089999999513E-05 |
| Normal-vs-Asian |
6.95300000019827E-07 |
| Caucasian-vs-AfricanAmerican |
8.268800E-01 |
| Caucasian-vs-Asian |
5.964400E-01 |
| AfricanAmerican-vs-Asian |
8.622400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.29520000069894E-08 |
| Normal-vs-Female |
8.28226376370367E-12 |
| Male-vs-Female |
4.461200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.12469999985687E-07 |
| Normal-vs-Age(41-60Yrs) |
1.38840050567524E-11 |
| Normal-vs-Age(61-80Yrs) |
5.37699995639684E-10 |
| Normal-vs-Age(81-100Yrs) |
3.61100000000336E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.680280E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.636200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.799890E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.717600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.978400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.452200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.396900E-03 |
| Classical-VS-Follicular |
3.364800E-01 |
| Classical-VS-Other |
3.777600E-01 |
| Classical-VS-Normal |
1.02870045814996E-10 |
| Tall-VS-Follicular |
5.428400E-04 |
| Tall-VS-Other |
9.119800E-02 |
| Tall-VS-Normal |
2.20909956993864E-11 |
| Follicular-VS-Other |
7.420600E-01 |
| Follicular-VS-Normal |
6.24390000000252E-05 |
| Other-VS-Normal |
9.789900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56999968581317E-11 |
| Normal-vs-N1 |
5.58390000904296E-09 |
| N0-vs-N1 |
7.749000E-01 |
|
|
